| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/26/2006 | WO2006008074A1 Gene therapy of solid tumours by means of retroviral vectors pseudotyped with arenavirus glycoproteins |
| 01/26/2006 | WO2005103272A3 Pan cancer oncolytic vectors and methods of use thereof |
| 01/26/2006 | WO2005086922A3 Oncolytic adenovirus armed with therapeutic genes |
| 01/26/2006 | WO2005070467A3 Method of protecting sensitive molecules from a photopolymerizing environment |
| 01/26/2006 | WO2005055979A3 Ph triggerable polymeric particles or films containing a poly (beta-amino ester) |
| 01/26/2006 | WO2005046605A3 Compositions and methods of treating neurological diseases |
| 01/26/2006 | WO2005037233A3 Listeria-based epha2 vaccines |
| 01/26/2006 | WO2004108087A3 Gene delivery to organs |
| 01/26/2006 | WO2004098534A3 Methods for delivering angiogenic modulators using pox viruses |
| 01/26/2006 | WO2004072266A3 Antibody affinity engineering by serial epitope-guided complementarity replacement |
| 01/26/2006 | WO2004018630A3 Recombinant double-stranded rna phages and uses thereof |
| 01/26/2006 | US20060019924 used in neuroblastoma therapy and diagnosis |
| 01/26/2006 | US20060019923 Methods and compositions for inducing innate immune responses |
| 01/26/2006 | US20060019922 Selective killing of cancerous cells |
| 01/26/2006 | US20060019921 Nucleic acid adjuvants |
| 01/26/2006 | US20060019920 Antisense modulation of MEKK4 expression |
| 01/26/2006 | US20060019919 Immunostimulatory oligonucleotide multimers |
| 01/26/2006 | US20060019918 Modulation of immunostimulatory properties of oligonucleotide-based compounds by utilizing modified immunostimulatory dinucleotides |
| 01/26/2006 | US20060019917 For ocular disease, cancer and proliferative diseases |
| 01/26/2006 | US20060019916 Immunostimulatory nucleic acids for inducing IL-10 responses |
| 01/26/2006 | US20060019915 Method to modulate the immune system with a novel guanine nucleotide exchange factor |
| 01/26/2006 | US20060019914 Inhibition of tumor growth and invasion by anti-matrix metalloproteinase DNAzymes |
| 01/26/2006 | US20060019913 chemically synthesized double stranded siNA that directs cleavage of a protein tyrosine phosphatase-1B RNA; use to treat obesity, insulin resistance, diabetes |
| 01/26/2006 | US20060019912 Cell transfecting formulations of small interfering RNA related compositions and methods of making and use |
| 01/26/2006 | US20060019911 Drug-carrier complexes and methods of use thereof |
| 01/26/2006 | US20060019910 Inhibiting c Jun amino terminal kinase signal transduction pathway; reducing tumor necrosis factor alpha induced lipolysis |
| 01/26/2006 | US20060019909 Modulation of immunostimulatory properties of oligonucleotide-based compounds by optimal presentation of 5' ends |
| 01/26/2006 | US20060019888 such as viral myocarditis (Coxsackie virus, echovirus, polio virus) or dilated (congestive) cardiomyopathy, by binding ErbB2-ErbB4 receptors; atpase inhibitors |
| 01/26/2006 | US20060019394 DNA segment from a BIV genome; a packaging sequence to package RNA into virions; a first promoter operably linked to the DNA segment; d) a transgene operably linked to a second promoter and deletion of vpw, vpy and tat from the construct |
| 01/26/2006 | US20060019393 Minimal lentiviral vector system |
| 01/26/2006 | US20060019392 Novel bone mineralization proteins, DNA, vectors, expression systems |
| 01/26/2006 | US20060019382 Transcriptionally-activated AAV inverted terminal repeats (ITRs) for use with recombinant AAV vectors |
| 01/26/2006 | US20060019381 comprises heat shock proteins LINKED TO POLYNUCLEOTIDE ENCODING HIV-TAT TRANSACTIVATING FACTOR, WHICH ACTIVATES HIV-2 PROMOTER |
| 01/26/2006 | US20060019380 Genetic vaccines directed against bacterial exotoxins |
| 01/26/2006 | US20060019369 for the production of reconstituted HCMV virus retaining phenotypic characteristics of a clinical virus isolate including the ability to grow on endothelial cells and to induce microfusion |
| 01/26/2006 | US20060019322 Nucleotide sequence coding polypeptide for use in diagnosis and therapy of prostate cancer |
| 01/26/2006 | US20060019261 RNA-binding protein |
| 01/26/2006 | US20060019240 Posh nucleic acids, polypeptides and related methods |
| 01/26/2006 | US20060019239 enhancing the immunogenicity of a vaccine against Bacillus anthracis by administering an oligodeoxynucleotide with a vaccine against Bacillus anthracis; Anthrax Vaccine Adsorbed (AVA) vaccine |
| 01/26/2006 | US20060018971 Nucleic acid microspheres, production and delivery thereof |
| 01/26/2006 | US20060018930 Compositions comprising viruses and methods for concentrating virus preparations |
| 01/26/2006 | US20060018929 Protein kinase deficient, immunologically active CMVpp65 mutants |
| 01/26/2006 | US20060018920 Lawsonia derived gene and related OmpH polypeptides, peptides and proteins and their uses |
| 01/26/2006 | US20060018917 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 01/26/2006 | US20060018900 Self antigen vaccines for treating B-cell lymphomas and other cancers |
| 01/26/2006 | US20060018895 Murine monoclonal anti-idiotype antibody 11D10 and methods of use thereof |
| 01/26/2006 | US20060018893 Method for determining modulation of P110delta activity |
| 01/26/2006 | US20060018889 Methods and compositions for bone marrow stem cell-derived macrophage delivery of genes for gene therapy |
| 01/26/2006 | US20060018888 Suicidal mutant leishmania vaccine |
| 01/26/2006 | US20060018886 culturing a multilayer of human embryonic stem cells, for a sufficient time to allow for the appearance of putative cells comprising brown pigment dispersed within their cytoplasm, culturing the putative cells to form a cell monolayer containing cells that are Pax6 negative and bestrophin positive |
| 01/26/2006 | US20060018885 Methods for increasing HSC graft efficiency |
| 01/26/2006 | US20060018884 Method for treating human tumor cells with a newcastle disease virus strain and a chemotherapeutic agent |
| 01/26/2006 | US20060018882 Medical devices and methods for delivering compositions to cells |
| 01/26/2006 | US20060018881 Coordinate in vivo gene expression |
| 01/26/2006 | US20060018880 Methods and compositions for delivery of an enhanced response to antigenic substrates |
| 01/26/2006 | US20060018879 Expression vectors for treating bacterial infections |
| 01/26/2006 | US20060018878 Dual antigen specific T cells with trafficking ability |
| 01/26/2006 | US20060018871 aptamer PEG conjugate; transplant rejection; angioplasty; restenosis; specificity and affinity of the aptamer can be tightly controlled and allows the generation of leads; no toxicity or immunogenicity; chemical stability |
| 01/26/2006 | US20060018841 AAV vectors for gene delivery to the lung |
| 01/26/2006 | US20060018838 Vacsularized tissue for transplantation |
| 01/26/2006 | US20060018826 Biologic modulations with nanoparticles |
| 01/26/2006 | CA2570998A1 Improved efficacy of active immunotherapy by integrating diagnostic with therapeutic methods |
| 01/26/2006 | CA2570887A1 Tumor treatment |
| 01/25/2006 | EP1619254A1 Transfer of mRNA using polycationic compounds |
| 01/25/2006 | EP1619249A1 Induction of exon skipping in eukaryotic cells |
| 01/25/2006 | EP1619202A2 immunotherapeutic methods using epitopes of wt-1 and gata-1 |
| 01/25/2006 | EP1618898A2 Methods for regulating angiogenesis |
| 01/25/2006 | EP1618897A1 Lipid membrane structure containing anti-mt-mmp monoclonal antibody |
| 01/25/2006 | EP1618205A2 Methods of treating diseases responsive to induction of apoptosis and screening assays |
| 01/25/2006 | EP1618201A1 Vp2 - modified raav vectors and uses thereof |
| 01/25/2006 | EP1618191A2 Recombinant influenza viruses holding a mutation in a transmembrane protein gene |
| 01/25/2006 | EP1618189A2 Rnai agents for anti-sars coronavirus therapy |
| 01/25/2006 | EP1618184A2 Epha2, hypoproliferative cell disorders and epithelial and endothelial reconstitution |
| 01/25/2006 | EP1617875A1 Novel use of aim3 acting as a tumor suppressor |
| 01/25/2006 | EP1617874A4 Devices and processes for distribution of genetic material to mammalian limb |
| 01/25/2006 | EP1617874A1 Devices and processes for distribution of genetic material to mammalian limb |
| 01/25/2006 | EP1617871A2 Delivery of immune response modifier compounds using metal-containing particulate support materials |
| 01/25/2006 | EP1617808A2 Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds |
| 01/25/2006 | EP1617722A2 Treating hepatocellular carcinomas using therapeutic viruses |
| 01/25/2006 | EP1520014A4 Tocopherol associated protein and uses thereof |
| 01/25/2006 | EP1490692B1 Diagnostic and therapeutic use of caps |
| 01/25/2006 | EP1461071A4 Muscle transcription factors |
| 01/25/2006 | EP1151121B1 Recombined porcine adenovirus based viral vaccines and vectors |
| 01/25/2006 | EP1080202B1 Convection-enhanced delivery of aav vectors encoding aadc |
| 01/25/2006 | EP1051495B1 Recombinant mistletoe lectines |
| 01/25/2006 | EP0980427B1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 01/25/2006 | CN1726287A Method of distinguishing drug-resistance of hepatitis b virus |
| 01/25/2006 | CN1726285A Methods and compositions for immunization against HIV |
| 01/25/2006 | CN1726283A Production of multimeric fusion proteins using a C4BP scaffold |
| 01/25/2006 | CN1726276A Production of ALVAC on avian embryonic stem cells |
| 01/25/2006 | CN1726227A Humanized antibody (H14.18) of the mouse 14.18 antibody binding to GD2 and its fusion with 1L-2 |
| 01/25/2006 | CN1724687A Relativity of proangiotension transferase 2 gene and prinary hypertension |
| 01/25/2006 | CN1724516A Natural and synthetic isothiocyanate kind compound and its application in treating and preventing cancer |
| 01/25/2006 | CN1238522C Interleukin-2 and test method of its gene in drug-stopping application |
| 01/25/2006 | CN1238504C Tumour related gene and use thereof |
| 01/25/2006 | CN1238382C Molt-inhibiting hormone-1 protein of mitten crab |
| 01/25/2006 | CN1238367C Isolated nucleic acid molecules which encode T cell inducible factors (TIF), proteins encoded, and uses thereof |
| 01/25/2006 | CN1238058C Implanting device with anti-DNA lgM-DNA compound and preparation method thereof |
| 01/25/2006 | CN1238057C Method of commutating and accelerating gene microsphere and gene gun |
| 01/24/2006 | US6989434 cationic lipids containing stigmasterol, ergosterol and cholic acid groups; for transfecting a cell |